PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.31%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
2.08%
Gross profit growth under 50% of QCOM's 26.26%. Michael Burry would be concerned about a severe competitive disadvantage.
24.74%
EBIT growth below 50% of QCOM's 112.73%. Michael Burry would suspect deeper competitive or cost structure issues.
24.74%
Operating income growth under 50% of QCOM's 112.73%. Michael Burry would be concerned about deeper cost or sales issues.
587.55%
Net income growth above 1.5x QCOM's 114.66%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
558.82%
EPS growth above 1.5x QCOM's 133.33%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
568.75%
Diluted EPS growth above 1.5x QCOM's 100.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.89%
Slight or no buybacks while QCOM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.76%
Slight or no buyback while QCOM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-3.88%
Dividend reduction while QCOM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-9.44%
Negative OCF growth while QCOM is at 168.06%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-26.97%
Negative FCF growth while QCOM is at 79.85%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
41.78%
10Y revenue/share CAGR under 50% of QCOM's 19971.26%. Michael Burry would suspect a lasting competitive disadvantage.
2.59%
5Y revenue/share CAGR under 50% of QCOM's 7558.62%. Michael Burry would suspect a significant competitive gap or product weakness.
-7.06%
Negative 3Y CAGR while QCOM stands at 3098.59%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
37.89%
Below 50% of QCOM's 5482.54%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
31.84%
3Y OCF/share CAGR under 50% of QCOM's 1260.94%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
2355.49%
10Y net income/share CAGR of 2355.49% while QCOM is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
2232.04%
Below 50% of QCOM's 23999.38%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
780.74%
Below 50% of QCOM's 2372.35%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
146.09%
Below 50% of QCOM's 5627.85%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
111.23%
Below 50% of QCOM's 1528.57%. Michael Burry suspects a serious short-term disadvantage in building book value.
84.04%
Dividend/share CAGR of 84.04% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
8.03%
Dividend/share CAGR of 8.03% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
39.18%
3Y dividend/share CAGR of 39.18% while QCOM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-0.17%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.85%
Inventory shrinking or stable vs. QCOM's 10.35%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
28.62%
Asset growth above 1.5x QCOM's 0.50%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
40.37%
BV/share growth above 1.5x QCOM's 5.11%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.41%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-1.79%
Our R&D shrinks while QCOM invests at 22.10%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-11.65%
We cut SG&A while QCOM invests at 26.02%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.